newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals Announces Closing of Initial Public Offering

PHILADELPHIA, PA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON) (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...